- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Market Overview
The Biomarker market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Biomarker market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 12.2%% in the forecast period of 2020 to 2025 and will expected to reach USD 42540 million by 2025, from USD 26890 million in 2019.
Market segmentation
Biomarker market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Biomarker market has been segmented into:
Consumables
Service
By Application, Biomarker has been segmented into:
Diagnostics Development
Drug Discovery and Development
Disease-Risk
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biomarker market presented in the report. This section sheds light on the sales growth of different regional and country-level Biomarker markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biomarker market.
The report offers in-depth assessment of the growth and other aspects of the Biomarker market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Biomarker Market Share Analysis
Biomarker competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biomarker sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biomarker sales, revenue and market share for each player covered in this report.
The major players covered in Biomarker are:
QIAGEN N.V. (Netherlands)
Bio-Rad Laboratories, Inc. (U.S.)
PerkinElmer, Inc. (U.S.)
Merck Millipore (U.S.)
Enzo Biochem, Inc. (U.S.)
Among other players domestic and global, Biomarker market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Biomarker Market Overview
1.1 Product Overview and Scope of Biomarker
1.2 Classification of Biomarker by Type
1.2.1 Global Biomarker Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Biomarker Revenue Market Share by Type in 2019
1.2.3 Consumables
1.2.4 Service
1.3 Global Biomarker Market by Application
1.3.1 Overview: Global Biomarker Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Diagnostics Development
1.3.3 Drug Discovery and Development
1.3.4 Disease-Risk
1.4 Global Biomarker Market by Regions
1.4.1 Global Biomarker Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Biomarker (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Biomarker Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Biomarker Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biomarker Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Biomarker Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biomarker Status and Prospect (2015-2025)
2 Company Profiles
2.1 QIAGEN N.V. (Netherlands)
2.1.1 QIAGEN N.V. (Netherlands) Details
2.1.2 QIAGEN N.V. (Netherlands) Major Business
2.1.3 QIAGEN N.V. (Netherlands) SWOT Analysis
2.1.4 QIAGEN N.V. (Netherlands) Product and Services
2.1.5 QIAGEN N.V. (Netherlands) Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bio-Rad Laboratories, Inc. (U.S.)
2.2.1 Bio-Rad Laboratories, Inc. (U.S.) Details
2.2.2 Bio-Rad Laboratories, Inc. (U.S.) Major Business
2.2.3 Bio-Rad Laboratories, Inc. (U.S.) SWOT Analysis
2.2.4 Bio-Rad Laboratories, Inc. (U.S.) Product and Services
2.2.5 Bio-Rad Laboratories, Inc. (U.S.) Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.3 PerkinElmer, Inc. (U.S.)
2.3.1 PerkinElmer, Inc. (U.S.) Details
2.3.2 PerkinElmer, Inc. (U.S.) Major Business
2.3.3 PerkinElmer, Inc. (U.S.) SWOT Analysis
2.3.4 PerkinElmer, Inc. (U.S.) Product and Services
2.3.5 PerkinElmer, Inc. (U.S.) Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck Millipore (U.S.)
2.4.1 Merck Millipore (U.S.) Details
2.4.2 Merck Millipore (U.S.) Major Business
2.4.3 Merck Millipore (U.S.) SWOT Analysis
2.4.4 Merck Millipore (U.S.) Product and Services
2.4.5 Merck Millipore (U.S.) Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.5 Enzo Biochem, Inc. (U.S.)
2.5.1 Enzo Biochem, Inc. (U.S.) Details
2.5.2 Enzo Biochem, Inc. (U.S.) Major Business
2.5.3 Enzo Biochem, Inc. (U.S.) SWOT Analysis
2.5.4 Enzo Biochem, Inc. (U.S.) Product and Services
2.5.5 Enzo Biochem, Inc. (U.S.) Biomarker Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Biomarker Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Biomarker Players Market Share
3.2.2 Top 10 Biomarker Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Biomarker Revenue and Market Share by Regions
4.2 North America Biomarker Revenue and Growth Rate (2015-2020)
4.3 Europe Biomarker Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Biomarker Revenue and Growth Rate (2015-2020)
4.5 South America Biomarker Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Biomarker Revenue and Growth Rate (2015-2020)
5 North America Biomarker Revenue by Countries
5.1 North America Biomarker Revenue by Countries (2015-2020)
5.2 USA Biomarker Revenue and Growth Rate (2015-2020)
5.3 Canada Biomarker Revenue and Growth Rate (2015-2020)
5.4 Mexico Biomarker Revenue and Growth Rate (2015-2020)
6 Europe Biomarker Revenue by Countries
6.1 Europe Biomarker Revenue by Countries (2015-2020)
6.2 Germany Biomarker Revenue and Growth Rate (2015-2020)
6.3 UK Biomarker Revenue and Growth Rate (2015-2020)
6.4 France Biomarker Revenue and Growth Rate (2015-2020)
6.5 Russia Biomarker Revenue and Growth Rate (2015-2020)
6.6 Italy Biomarker Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Biomarker Revenue by Regions
7.1 Asia-Pacific Biomarker Revenue by Regions (2015-2020)
7.2 China Biomarker Revenue and Growth Rate (2015-2020)
7.3 Japan Biomarker Revenue and Growth Rate (2015-2020)
7.4 Korea Biomarker Revenue and Growth Rate (2015-2020)
7.5 India Biomarker Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Biomarker Revenue and Growth Rate (2015-2020)
8 South America Biomarker Revenue by Countries
8.1 South America Biomarker Revenue by Countries (2015-2020)
8.2 Brazil Biomarker Revenue and Growth Rate (2015-2020)
8.3 Argentina Biomarker Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Biomarker by Countries
9.1 Middle East & Africa Biomarker Revenue by Countries (2015-2020)
9.2 Saudi Arabia Biomarker Revenue and Growth Rate (2015-2020)
9.3 UAE Biomarker Revenue and Growth Rate (2015-2020)
9.4 Egypt Biomarker Revenue and Growth Rate (2015-2020)
9.5 South Africa Biomarker Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Biomarker Revenue and Market Share by Type (2015-2020)
10.2 Global Biomarker Market Forecast by Type (2019-2024)
10.3 Consumables Revenue Growth Rate (2015-2025)
10.4 Service Revenue Growth Rate (2015-2025)
11 Global Biomarker Market Segment by Application
11.1 Global Biomarker Revenue Market Share by Application (2015-2020)
11.2 Biomarker Market Forecast by Application (2019-2024)
11.3 Diagnostics Development Revenue Growth (2015-2020)
11.4 Drug Discovery and Development Revenue Growth (2015-2020)
11.5 Disease-Risk Revenue Growth (2015-2020)
12 Global Biomarker Market Size Forecast (2021-2025)
12.1 Global Biomarker Market Size Forecast (2021-2025)
12.2 Global Biomarker Market Forecast by Regions (2021-2025)
12.3 North America Biomarker Revenue Market Forecast (2021-2025)
12.4 Europe Biomarker Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Biomarker Revenue Market Forecast (2021-2025)
12.6 South America Biomarker Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Biomarker Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global Biomarker Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biomarker by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biomarker Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Biomarker Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Biomarker Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. QIAGEN N.V. (Netherlands) Corporate Information, Location and Competitors
Table 7. QIAGEN N.V. (Netherlands) Biomarker Major Business
Table 8. QIAGEN N.V. (Netherlands) Biomarker Total Revenue (USD Million) (2017-2018)
Table 9. QIAGEN N.V. (Netherlands) SWOT Analysis
Table 10. QIAGEN N.V. (Netherlands) Biomarker Product and Solutions
Table 11. QIAGEN N.V. (Netherlands) Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Bio-Rad Laboratories, Inc. (U.S.) Corporate Information, Location and Competitors
Table 13. Bio-Rad Laboratories, Inc. (U.S.) Biomarker Major Business
Table 14. Bio-Rad Laboratories, Inc. (U.S.) Biomarker Total Revenue (USD Million) (2018-2019)
Table 15. Bio-Rad Laboratories, Inc. (U.S.) SWOT Analysis
Table 16. Bio-Rad Laboratories, Inc. (U.S.) Biomarker Product and Solutions
Table 17. Bio-Rad Laboratories, Inc. (U.S.) Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. PerkinElmer, Inc. (U.S.) Corporate Information, Location and Competitors
Table 19. PerkinElmer, Inc. (U.S.) Biomarker Major Business
Table 20. PerkinElmer, Inc. (U.S.) Biomarker Total Revenue (USD Million) (2017-2018)
Table 21. PerkinElmer, Inc. (U.S.) SWOT Analysis
Table 22. PerkinElmer, Inc. (U.S.) Biomarker Product and Solutions
Table 23. PerkinElmer, Inc. (U.S.) Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Merck Millipore (U.S.) Corporate Information, Location and Competitors
Table 25. Merck Millipore (U.S.) Biomarker Major Business
Table 26. Merck Millipore (U.S.) Biomarker Total Revenue (USD Million) (2017-2018)
Table 27. Merck Millipore (U.S.) SWOT Analysis
Table 28. Merck Millipore (U.S.) Biomarker Product and Solutions
Table 29. Merck Millipore (U.S.) Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Enzo Biochem, Inc. (U.S.) Corporate Information, Location and Competitors
Table 31. Enzo Biochem, Inc. (U.S.) Biomarker Major Business
Table 32. Enzo Biochem, Inc. (U.S.) Biomarker Total Revenue (USD Million) (2017-2018)
Table 33. Enzo Biochem, Inc. (U.S.) SWOT Analysis
Table 34. Enzo Biochem, Inc. (U.S.) Biomarker Product and Solutions
Table 35. Enzo Biochem, Inc. (U.S.) Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Global Biomarker Revenue (Million USD) by Players (2015-2020)
Table 37. Global Biomarker Revenue Share by Players (2015-2020)
Table 38. Global Biomarker Revenue (Million USD) by Regions (2015-2020)
Table 39. Global Biomarker Revenue Market Share by Regions (2015-2020)
Table 40. North America Biomarker Revenue by Countries (2015-2020)
Table 41. North America Biomarker Revenue Market Share by Countries (2015-2020)
Table 42. Europe Biomarker Revenue (Million USD) by Countries (2015-2020)
Table 43. Asia-Pacific Biomarker Revenue (Million USD) by Regions (2015-2020)
Table 44. South America Biomarker Revenue by Countries (2015-2020)
Table 45. South America Biomarker Revenue Market Share by Countries (2015-2020)
Table 46. Middle East and Africa Biomarker Revenue (Million USD) by Countries (2015-2020)
Table 47. Middle East and Africa Biomarker Revenue Market Share by Countries (2015-2020)
Table 48. Global Biomarker Revenue (Million USD) by Type (2015-2020)
Table 49. Global Biomarker Revenue Share by Type (2015-2020)
Table 50. Global Biomarker Revenue Forecast by Type (2021-2025)
Table 51. Global Biomarker Revenue by Application (2015-2020)
Table 52. Global Biomarker Revenue Share by Application (2015-2020)
Table 53. Global Biomarker Revenue Forecast by Application (2021-2025)
Table 54. Global Biomarker Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Biomarker Picture
Figure 2. Global Biomarker Revenue Market Share by Type in 2019
Figure 3. Consumables Picture
Figure 4. Service Picture
Figure 5. Biomarker Revenue Market Share by Application in 2019
Figure 6. Diagnostics Development Picture
Figure 7. Drug Discovery and Development Picture
Figure 8. Disease-Risk Picture
Figure 9. Global Biomarker Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Biomarker Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Biomarker Revenue Market Share in 2019
Figure 18. Global Top 10 Players Biomarker Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Biomarker Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Biomarker Revenue Market Share by Regions (2015-2020)
Figure 22. Global Biomarker Revenue Market Share by Regions in 2018
Figure 23. North America Biomarker Revenue and Growth Rate (2015-2020)
Figure 24. Europe Biomarker Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Biomarker Revenue and Growth Rate (2015-2020)
Figure 26. South America Biomarker Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Biomarker Revenue and Growth Rate (2015-2020)
Figure 28. North America Biomarker Revenue Market Share by Countries (2015-2020)
Figure 29. North America Biomarker Revenue Market Share by Countries in 2019
Figure 30. USA Biomarker Revenue and Growth Rate (2015-2020)
Figure 31. Canada Biomarker Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Biomarker Revenue and Growth Rate (2015-2020)
Figure 33. Europe Biomarker Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Biomarker Revenue Market Share by Countries in 2019
Figure 35. Germany Biomarker Revenue and Growth Rate (2015-2020)
Figure 36. UK Biomarker Revenue and Growth Rate (2015-2020)
Figure 37. France Biomarker Revenue and Growth Rate (2015-2020)
Figure 38. Russia Biomarker Revenue and Growth Rate (2015-2020)
Figure 39. Italy Biomarker Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Biomarker Revenue Market Share by Regions (2015-2020)
Figure 41. Asia-Pacific Biomarker Revenue Market Share by Regions in 2019
Figure 42. China Biomarker Revenue and Growth Rate (2015-2020)
Figure 43. Japan Biomarker Revenue and Growth Rate (2015-2020)
Figure 44. Korea Biomarker Revenue and Growth Rate (2015-2020)
Figure 45. India Biomarker Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Biomarker Revenue and Growth Rate (2015-2020)
Figure 47. South America Biomarker Revenue Market Share by Countries (2015-2020)
Figure 48. South America Biomarker Revenue Market Share by Countries in 2019
Figure 49. Brazil Biomarker Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Biomarker Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Biomarker Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Biomarker Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Biomarker Revenue and Growth Rate (2015-2020)
Figure 54. UAE Biomarker Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Biomarker Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Biomarker Revenue and Growth Rate (2015-2020)
Figure 57. Global Biomarker Revenue Share by Type (2015-2020)
Figure 58. Global Biomarker Revenue Share by Type in 2019
Figure 59. Global Biomarker Market Share Forecast by Type (2021-2025)
Figure 60. Global Consumables Revenue Growth Rate (2015-2020)
Figure 61. Global Service Revenue Growth Rate (2015-2020)
Figure 62. Global Biomarker Revenue Share by Application (2015-2020)
Figure 63. Global Biomarker Revenue Share by Application in 2019
Figure 64. Global Biomarker Market Share Forecast by Application (2021-2025)
Figure 65. Global Diagnostics Development Revenue Growth Rate (2015-2020)
Figure 66. Global Drug Discovery and Development Revenue Growth Rate (2015-2020)
Figure 67. Global Disease-Risk Revenue Growth Rate (2015-2020)
Figure 68. Global Biomarker Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Biomarker Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Biomarker Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Biomarker Revenue Market Forecast (2021-2025)
Figure 72. Europe Biomarker Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Biomarker Revenue Market Forecast (2021-2025)
Figure 74. South America Biomarker Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Biomarker Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Please feel free to write an email to us or to use our electronic ticketing system.
